Fifty Years of Unraveling the Clinical Pharmacology of Corticosteroids.

Document Type

Article

Publication Date

1-2024

Identifier

DOI: 10.1016/j.xphs.2023.10.016

Abstract

This review will highlight portions of Dr. William Jusko's and colleagues' work that affected the clinical use and study of corticosteroids in acute and chronic disease management. Selected publications related to corticosteroid pharmacokinetics and pharmacodynamics from the 1970s through today were included in this review, with a focus on the foundational human-based studies conducted in the 1970s-1990s. Dr. Jusko contributed significantly to early corticosteroid pharmacology across several domains including: 1) foundational corticosteroid pharmacokinetic methods and parameter development, 2) disease state-variation in corticosteroid pharmacokinetics, 3) drug interaction effects on corticosteroid pharmacokinetics, and 4) early corticosteroid pharmacodynamic studies. In an era where little was known about the pharmacokinetics and pharmacodynamics of corticosteroids, Dr. Jusko's work opened the eyes of researchers and clinicians to the potential for disease and drug interactions that could reduce or enhance the effects of corticosteroids. This significant body of work paved the way for alternative routes of administration that would be useful in concentrating the activity at the site of action and markedly reduced systemic drug exposure, minimizing the risk of adverse effects through application of the dose-sparing pharmacokinetic and pharmacodynamic principles.

Journal Title

Journal of pharmaceutical sciences

Volume

113

Issue

1

First Page

47

Last Page

54

MeSH Keywords

Humans; Adrenal Cortex Hormones; Drug Interactions; Pharmacology, Clinical

Keywords

Asthma; Corticosteroids; Cortisol; Cystic fibrosis; Disease management; Drug interactions; Methylprednisolone; Prednisolone; Prednisone; Steroid-resistant asthma; Transcortin

Link to Full Text
Library Record

Share

COinS